The NMDA-receptor antagonist ketamine has proven efficient in reducing symptoms of suicidality, although the mechanisms explaining this effect have not been detailed in psychiatric patients. Recent evidence points towards a low-grade inflammation in brains of suicide victims. Inflammation leads to p...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!